Stay updated on Efgartigimod Safety & Efficacy in pSS Clinical Trial

Sign up to get notified when there's something new on the Efgartigimod Safety & Efficacy in pSS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efgartigimod Safety & Efficacy in pSS Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0; previous revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-20T04:07:44.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3 in the footer, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-05T18:51:29.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2, representing a minor update with no impact on study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:19:25.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1; this is a metadata/version control change and does not modify study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T01:29:50.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Added a glossary display and a new QC-related metadata label (Last Update Submitted that Met QC Criteria) with a revision reference (v3.4.0), and adjusted capitalization of No FEAR Act data across the page.
    Difference
    0.2%
    Check dated 2026-01-28T21:36:03.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4, and this change does not modify study content, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:00:44.000Z thumbnail image

Stay in the know with updates to Efgartigimod Safety & Efficacy in pSS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efgartigimod Safety & Efficacy in pSS Clinical Trial page.